Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
Clinical trial NCT00403325 · COMPLETED
Trial details
- NCT number
- NCT00403325
- Sponsor
- Vitreous -Retina- Macula Consultants of New York
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.